(1)
The Impact of Recipient HLA-Cw and Donor Killer Immunoglobulin-Like Receptor Genotyping on the Outcome of Patients Receiving HLA-Matched Sibling Donor Haematopoietic Stem Cell Transplantation for Myeloid Malignancies. Swiss Med Wkly 2012, 143 (0102), w13717. https://doi.org/10.4414/smw.2013.13717.